{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:31:28Z","timestamp":1760189488935},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.bulcan.2016.02.002","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T04:45:37Z","timestamp":1458017137000},"page":"444-454","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["M\u00e9thotrexate intrath\u00e9cal dans les m\u00e9ningites carcinomateuses du cancer du sein \u2013 Exp\u00e9rience avec le protocole utilis\u00e9 \u00e0 l\u2019h\u00f4pital Saint-Louis"],"prefix":"10.1016","volume":"103","author":[{"given":"Delphine","family":"Cochereau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Da Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Le Maignan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Cochereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Espi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Giacchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2016.02.002_bib0165","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S1470-2045(10)70034-6","article-title":"Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours","volume":"11","author":"Beauchesne","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jso.2930230311","article-title":"Breast carcinoma: pattern of metastasis at autopsy","volume":"23","author":"Lee","year":"1983","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0175","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B","article-title":"Central nervous system metastasis from breast carcinoma. Autopsy study","volume":"52","author":"Tsukada","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0180","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11910-002-0081-7","article-title":"Neoplastic meningitis","volume":"2","author":"Aparicio","year":"2002","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10549-014-3054-z","article-title":"Leptomeningeal disease and breast cancer: the importance of tumor subtype","volume":"146","author":"Abouharb","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0190","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/CCO.0b013e32833de986","article-title":"Leptomeningeal metastasis","volume":"22","author":"Chamberlain","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0195","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1684\/bdc.2011.1340","article-title":"[M\u00e9ningites carcinomateuses des cancers du sein]","volume":"98","author":"Petithuguenin Gauthier","year":"2011","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-007-9340-4","article-title":"Breast cancer leptomeningeal metastasis \u2013 the role of multimodality treatment","volume":"84","author":"Rudnicka","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-013-1175-6","article-title":"Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis","volume":"114","author":"Yust-Katz","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0210","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11060-010-0524-y","article-title":"Meningeal carcinomatosis in breast cancer: prognostic factors and outcome","volume":"104","author":"de Azevedo","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0215","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1470-2045(12)70432-1","article-title":"Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (Landscape): a single-group phase\u00a02\u00a0study","volume":"14","author":"Bachelot","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0220","unstructured":"Association des neuro-oncologue d\u2019expression fran\u00e7aise (ANOCEF). http:\/\/www.anocef.org."},{"key":"10.1016\/j.bulcan.2016.02.002_bib0225","first-page":"2726","article-title":"The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study","volume":"40","author":"Boogerd","year":"2004","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0230","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","article-title":"Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis","volume":"11","author":"Grossman","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0235","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","article-title":"A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis","volume":"5","author":"Hitchins","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0240","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM197507242930402","article-title":"Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections","volume":"293","author":"Shapiro","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0245","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/neuonc\/nou089","article-title":"Leptomeningeal metastasis: a response assessment in neuro-oncology critical review of endpoints and response criteria of published randomized clinical trials","volume":"16","author":"Chamberlain","year":"2014","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0250","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4","article-title":"Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen","volume":"77","author":"Fizazi","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0255","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1634\/theoncologist.2008-0138","article-title":"Neoplastic meningitis","volume":"13","author":"Chamberlain","year":"2008","journal-title":"The Oncologist"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0260","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11060-008-9768-1","article-title":"Meningeal carcinomatosis in HER2-overexpressing breast cancers","volume":"93","author":"Bidard","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0265","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","article-title":"Repeated observation of breast tumor subtypes in independent gene expression data sets","volume":"100","author":"Sorlie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0270","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11060-013-1244-x","article-title":"Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa","volume":"115","author":"Comte","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0275","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11060-013-1092-8","article-title":"A retrospective case series of 103\u00a0consecutive patients with leptomeningeal metastasis and breast cancer","volume":"113","author":"Le Rhun","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0280","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/annonc\/mdq689","article-title":"Validation of the Institut Curie simplified prognostic score for breast cancer meningeal carcinomatosis","volume":"22","author":"Bidard","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0285","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/cncr.24921","article-title":"Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis","volume":"116","author":"Glantz","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0290","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","article-title":"Leptomeningeal carcinomatosis","volume":"25","author":"Grossman","year":"1999","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0295","article-title":"Intrathecal trastuzumab halts progression of CNS metastases in breast cancer","author":"Bousquet","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0300","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1684\/bdc.2011.1341","article-title":"[M\u00e9ningites carcinomateuses des cancers du sein surexprimant HER2\u00a0: pour un traitement sp\u00e9cifique\u00a0?]","volume":"98","author":"Gutierrez","year":"2011","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0305","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-013-2525-y","article-title":"Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis","volume":"139","author":"Zagouri","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0310","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/annonc\/mdu261","article-title":"Erlotinib treatment of meningeal carcinomatosis in lung cancer: more is better","volume":"25","author":"Cessot","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0315","first-page":"8017","article-title":"A phase\u00a0I study of twice weekly pulse dose and daily low dose erlotinib as initial treatment for patients (pts) with EGFR-mutant lung cancers","volume":"33","author":"Yu","year":"2015","journal-title":"ASCO Meet Abstr"},{"key":"10.1016\/j.bulcan.2016.02.002_bib0320","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrclinonc.2014.104","article-title":"Acquired resistance to TKIs in solid tumours: learning from lung cancer","volume":"11","author":"Camidge","year":"2014","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455116000618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455116000618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T04:04:21Z","timestamp":1655265861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455116000618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0007455116000618"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2016.02.002","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00e9thotrexate intrath\u00e9cal dans les m\u00e9ningites carcinomateuses du cancer du sein \u2013 Exp\u00e9rience avec le protocole utilis\u00e9 \u00e0 l\u2019h\u00f4pital Saint-Louis","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2016.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}